In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, EyePoint Pharmaceuticals Inc’s stock clocked out at $9.55, up 1.49% from its previous closing price of $9.41. In other words, the price has increased by $1.49 from its previous closing price. On the day, 0.77 million shares were traded. EYPT stock price reached its highest trading level at $9.595 during the session, while it also had its lowest trading level at $8.955.
Ratios:
To gain a deeper understanding of EYPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.79 and its Current Ratio is at 7.85. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on June 17, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.
On January 07, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $33.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 19 ’25 when Zaderej Karen L. bought 5,000 shares for $5.99 per share. The transaction valued at 29,950 led to the insider holds 36,500 shares of the business.
Zaderej Karen L. bought 5,000 shares of EYPT for $29,050 on May 16 ’25. The Director now owns 31,500 shares after completing the transaction at $5.81 per share. On May 15 ’25, another insider, Zaderej Karen L., who serves as the Director of the company, bought 5,000 shares for $5.47 each. As a result, the insider paid 27,350 and bolstered with 26,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 657151680 and an Enterprise Value of 353406432. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.73 while its Price-to-Book (P/B) ratio in mrq is 2.20. Its current Enterprise Value per Revenue stands at 6.306 whereas that against EBITDA is -2.214.
Stock Price History:
The Beta on a monthly basis for EYPT is 1.69, which has changed by 0.10788858 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, EYPT has reached a high of $13.98, while it has fallen to a 52-week low of $3.91. The 50-Day Moving Average of the stock is 28.50%, while the 200-Day Moving Average is calculated to be 22.07%.
Shares Statistics:
It appears that EYPT traded 851.38K shares on average per day over the past three months and 893490 shares per day over the past ten days. A total of 68.81M shares are outstanding, with a floating share count of 59.81M. Insiders hold about 13.08% of the company’s shares, while institutions hold 96.94% stake in the company. Shares short for EYPT as of 1749772800 were 6738690 with a Short Ratio of 7.92, compared to 1747267200 on 7206930. Therefore, it implies a Short% of Shares Outstanding of 6738690 and a Short% of Float of 11.74.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
